Evidence map›Paper›PMID 24939899›Full record

ArticleNucleic acids research2014

Conjugation with polyamines enhances the antibacterial and anticancer activity of chloramphenicol.

Ourania N Kostopoulou, Ekaterini C Kouvela, George E Magoulas, Thomas Garnelis, Ioannis Panagoulias, Maria Rodi, Georgios Papadopoulos, Athanasia Mouzaki, George P Dinos, Dionissios Papaioannou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Development of Responsive Nanoparticles for Cancer Therapy.International journal of molecular sciences · 2023
    Article
  3. Polyamine-Drug Conjugates: Do They Boost Drug Activity?Molecules (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ourania N KostopoulouDepartment of Biochemistry, School of Medicine, University of Patras, GR-26504 Patras, Greece.
Ekaterini C KouvelaDepartment of Biochemistry, School of Medicine, University of Patras, GR-26504 Patras, Greece.
George E MagoulasDivision of Hematology, Department of Internal Medicine, School of Medicine, University of Patras, GR-26504 Patras, Greece.
Thomas GarnelisDivision of Hematology, Department of Internal Medicine, School of Medicine, University of Patras, GR-26504 Patras, Greece.
Ioannis PanagouliasLaboratory of Synthetic Organic Chemistry, Department of Chemistry, University of Patras, GR-26504 Patras, Greece.
Maria RodiLaboratory of Synthetic Organic Chemistry, Department of Chemistry, University of Patras, GR-26504 Patras, Greece.
Georgios PapadopoulosDepartment of Biochemistry and Biotechnology, University of Thessaly, Ploutonos 26, GR-41221 Larissa, Greece.
Athanasia MouzakiLaboratory of Synthetic Organic Chemistry, Department of Chemistry, University of Patras, GR-26504 Patras, Greece.
George P DinosDepartment of Biochemistry, School of Medicine, University of Patras, GR-26504 Patras, Greece.
Dionissios PapaioannouDivision of Hematology, Department of Internal Medicine, School of Medicine, University of Patras, GR-26504 Patras, Greece.
Dimitrios L KalpaxisDepartment of Biochemistry, School of Medicine, University of Patras, GR-26504 Patras, Greece dimkal@med.upatras.gr.
University of Patras · GRUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chloramphenicol (CAM) is a broad-spectrum antibiotic, limited to occasional only use in developed countries because of its potential toxicity. To explore the influence of polyamines on the uptake and activity of CAM into cells, a series of polyamine-CAM conjugates were synthesized. Both polyamine architecture and the position of CAM-scaffold substitution were crucial in augmenting the antibacterial and anticancer potency of the synthesized conjugates. Compounds 4 and 5, prepared by replacement of dichloro-acetyl group of CAM with succinic acid attached to N4 and N1 positions of N(8),N(8)-dibenzylspermidine, respectively, exhibited higher activity than CAM in inhibiting the puromycin reaction in a bacterial cell-free system. Kinetic and footprinting analysis revealed that whereas the CAM-scaffold preserved its role in competing with the binding of aminoacyl-tRNA 3'-terminus to ribosomal A-site, the polyamine-tail could interfere with the rotatory motion of aminoacyl-tRNA 3'-terminus toward the P-site. Compared to CAM, compounds 4 and 5 exhibited comparable or improved antibacterial activity, particularly against CAM-resistant strains. Compound 4 also possessed enhanced toxicity against human cancer cells, and lower toxicity against healthy human cells. Thus, the designed conjugates proved to be suitable tools in investigating the ribosomal catalytic center plasticity and some of them exhibited greater efficacy than CAM itself.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBinding SitesCell Line, TumorChloramphenicolEscherichia coliHumansPolyaminesProtein Synthesis InhibitorsRibosomesAnti-Bacterial AgentsAntineoplastic AgentsChloramphenicolPolyaminesProtein Synthesis Inhibitors

Identifiers

PMID24939899
PMCPMC4117768
OpenAlexW2041004750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.